CD8A and neoplasm: The administration of post-Tx immunosuppressants keeps the recipients immunosuppressed for an extended period of time, resulting in decreased CD8+ cytotoxic T cells and low immune surveillance function, increasing susceptibility to viral infection and tumor incidence.